BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2021
Biohit Oyj Financial Statement Release 16 February 2022 at 9:30 am local time (EET) SUMMARY January-December 2021 · Revenue EUR 9.4 million (EUR 7.1 million) · Revenue grew by 31.4% compared to 2020 · Operative EBITDA EUR +0.5 million (EUR -1.2 million) · Cash at the end of the period EUR 1.1 million (EUR 1.0 million) · Fair value of Genetic Analysis AS investment EUR 0.9 million (EUR 0.8 million 31 December 2020) · Revenue from international operations 97.5% (96.1%) of total revenue · Equity ratio 76.3% (80.8%) July-December 2021 · Revenue EUR 5.3